Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 26.06.2026 FGOV LN IE00BKS2X200  108,638.00 GBP   1,607,124.63   17.136  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 26.06.2026 GFEB.LN IE000X8M8M80 700,002.00 USD 27,253,351.03 38.933  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 26.06.2026 GMAY.LN IE000P0FL8E3 1,200,002.00 USD 47,438,407.65 39.532  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 26.06.2026 IPXE.IM IE00BFD26097   50,002.00 EUR   1,296,672.18   25.932  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 26.06.2026 QSEP.LN IE000FQ808R5 400,002.00 USD 9,769,243.17 24.423  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 26.06.2026 CPQ IE00BFD2H405 6,550,002.00 USD 357,204,152.03   54.535  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 26.06.2026 FDNU IE00BG0SSC32 1,200,002.00 USD  42,876,718.90   35.731  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 26.06.2026 NQCYBREN IE00BF16M727 27,178,081.00 USD 1,445,022,524.10   53.169  ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LungFXTM device (LungFX) for use in centralized ex vivo lung perfusion (EVLP), a procedure that enables donor lungs to be assessed outside the body after procurement and before transplantation. The PMA, submitted by United Therapeutics’ wholly...

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop Capital Markets EMEA arranged a $191 million (€168.14 million) refinancing for a diversified portfolio in Netherlands....